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Abstract
Background:  Genes that play an important role in tumorigenesis are expected to show
association between DNA copy number and RNA expression. Optimal power to find such
associations can only be achieved if analysing copy number and gene expression jointly.
Furthermore, some copy number changes extend over larger chromosomal regions affecting the
expression levels of multiple resident genes.
Results: We propose to analyse copy number and expression array data using gene sets, rather
than individual genes. The proposed model is robust and sensitive. We re-analysed two publicly
available datasets as illustration. These two independent breast cancer datasets yielded similar
patterns of association between gene dosage and gene expression levels, in spite of different
platforms having been used. Our comparisons show a clear advantage to using sets of genes'
expressions to detect associations with long-spanning, low-amplitude copy number aberrations. In
addition, our model allows for using additional explanatory variables and does not require mapping
between copy number and expression probes.
Conclusion: We developed a general and flexible tool for integration of multiple microarray data
sets, and showed how the identification of genes whose expression is affected by copy number
aberrations provides a powerful approach to prioritize putative targets for functional validation.
Background
Tumor cells accumulate genetic damage, including
changes in DNA copy number, sequence and methyla-
tion, resulting in the dysfunctioning of key regulators [1].
The advent of microarray technology has allowed
genome-wide monitoring of these molecular changes at
the DNA and RNA level. Gene expression profiling has
facilitated classification of cancers into biologically and
clinically distinct categories [2-7]. High-resolution array-
based comparative genomic hybridization (array-CGH)
has allowed the delineation of recurrent DNA copy
number alterations in tumors [8-10]. Gene dosage
changes play an important role in tumor development;
oncogenes may be enhanced by DNA amplification and
tumor suppressor genes may be inactivated by a physical
deletion. Therefore, integrated analysis of both copy
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number and gene expression microarray data could give
additional information about the role of copy number
alterations in the development of cancer.
Combined analysis of DNA copy number and gene
expression microarrays of the same or similar tumor sam-
ples has revealed a major and direct effect of allelic imbal-
ance on gene expression in a variety of cancer types,
including breast [11,12], pancreatic [13], colorectal [14],
skin [15], head and neck [16,17], prostate [18], multiple
myeloma [19], and lung [20] cancer. On a global level,
40–60% of the genes in higher level amplifications
showed elevated expression, while circa 10% of highly
overexpressed genes were amplified [11,12]. In low-level
copy number aberrations, only about 10% of the genes
have been reported to show concordant changes in gene
expression [11,12,21].
Several approaches have been described to identify those
genes whose expression levels are most significantly asso-
ciated with copy number changes of the corresponding
genomic region.
In the context of natural copy number variation in human
populations, Stranger and co-authors [22] used a linear
regression model to study associations between gene
expression and copy number within a 2 Mb window. For
the analysis of tumor microarray data, some authors per-
formed a simultaneous exploratory analysis of the differ-
ent microarray datasets, ordered along the genome, to
search for regions where both copy number and gene
expression are affected [12,14,23,24], or gene expression
and DNA methylation [25]. While this can be clarifying if
an effect is found, due to the small effect sizes and the
often low signal-to-noise ratio in array data this approach
tends to be inefficient. For example, a two-fold change in
DNA copy number was observed to be accompanied on
average by 1.5-fold changes in mRNA levels in breast
tumors [12].
Other cancer studies classified samples according to the
presence of chromosomal abnormalities, and subse-
quently tested for differences in gene expression between
altered and unaltered samples. Some studies use a gene-
wise test statistic similar to the Student's t-statistic
[11,13,16,19] or a one-sided Wilcoxon rank-sums test
[25-27]. Garraway and co-authors [15] used supervised
analysis looking for gene expression differences between
cell lines with and without 3p amplification. Adler and
co-authors [28] used a classification approach as the first
step in their stepwise linkage analysis of microarray signa-
tures, where they test for differences in copy number
between groups of breast cancer samples with and with-
out the wound expression signature. While known and
novel tumor-related genes were identified, these
approaches may be unable to detect associations between
low-level copy number changes and expression variation
due to the categorization.
Low-level gains and losses, representing the most com-
mon types of genetic alterations in most cancers, were
shown to have a significant influence on expression levels
of genes in the regions affected, but these effects were
more subtle on a gene-by-gene basis [11,21]. However,
the impact of low-level gains on the dysregulation of gene
expression patterns in cancer may be equally important if
not more important than that of high-level amplifications
[11-13]. Therefore, the search for DNA regions that might
be involved in the initiation and progression of cancer
must be powerful enough to detect subtle gene-specific
effects that are possibly consistent across many genes.
Moreover, the analysis method must take into account the
high-dimensionality of the problem, and provide careful
control of the error.
We propose to look for associations between copy
number and expression not only using individual genes,
but also using gene sets. Such a model can improve the
power to detect associations, as neighbouring genes may
also display association. If different microarray platforms
are used to measure copy number and expression, it
involves less arbitrariness because no mapping between
copy number and expression probes is necessary. To illus-
trate these points, we first run a simulation study and then
apply our model to two publicly-available breast cancer
datasets. We will show that the use of gene sets is relevant
not only when studying the impact of large-amplitude
copy number changes (more than one copy gained or
lost), but also in case of more subtle changes, either of low
amplitude or spanning a small (<1 Mb) genomic region.
The discussion that follows includes other possible appli-
cations and useful extensions.
Results
We wish to find which individual copy number changes
affect gene expression levels within the same chromo-
somal region. For this, we propose to model copy number
as a function of the expression levels of many genes at the
same time. Statistically significant associations are indi-
cated by a significant p-value for the copy number probe,
and the genes with expression levels the most associated
with this outcome are prioritized in a heatmap. We evalu-
ate the power of this model in particular experimental set-
ups via a simulation study below. After this, we apply
both the gene-set model (2) and the gene-to-gene model
(1) to experimental datasets.
Simulation study
In order to illustrate the power of the model to identify
association patterns, we run a simulation study. We
assume for simplicity that both copy number and expres-
sion measurements are obtained using the same arrays, soBMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
Page 3 of 15
(page number not for citation purposes)
that there is a one-to-one correspondence between them.
The study is designed to represent various situations com-
monly encountered in practice, where typically 10–50%
of the samples display mild copy number effects spanning
a sizable genomic region (here 26% of the total probes),
such as part of a chromosome arm, or strong copy number
effects spanning a small region (here between 2 and 8% of
the total probes), typical of amplifications. Each probe's
expression level is assumed to be a function of its own
copy number, with various degrees of association. Key
parameters were estimated from publicly available data-
sets, amongst them the amount of variability of copy
number and expression measurements, as well as the dis-
tribution of the associations between copy number and
expression. Sample sizes of 25, 50 and 100 are considered.
We evaluate the results by producing receiver-operating
characteristic (ROC) curves of the regional model for each
case, and consider that an effect is detectable if there is
power of at least 60% to detect it using an FDR of 10%.
For more details about the study setup, see Appendix. The
results are reassuring, as the ROC curves in figure 1 illus-
trate. The association most reliably detected is the ampli-
fication (log-ratio 2) spanning 20 probes, detectable in all
situations. But as the total region size increases the pro-
portion of affected probes decreases, with the effect
becoming diluted, in particular if the sample size is small
(25).
The effect least reliably detected is the one-copy gain due
to the small amplitude (log-ratio 0.5): it is only detectable
when 50% of 100 samples are affected and the region
spans at least 500 probes. The one-copy loss is detectable
in all situations with sample size at least 50. Note that,
because the mild effects involve a fixed proportion of 26%
of the probes, the power to detect them increases with the
region length.
In practice, the amplitudes of recurrent copy number
changes vary more, therefore associations between contin-
uous copy number measurements and gene expression
levels can also be detected for smaller sample sizes and
less-frequent aberrations.
Breast cancer I: Pollack
Pollack and co-authors [12] produced and were the first to
analyse this dataset, consisting of copy number and
expression array data for 37 breast tumors and 4 breast-
tumor cell lines, produced on the same cDNA microar-
rays. The datasets pre-processed by the authors were
downloaded, consisting of log-ratios per gene. The
curated dataset involved 4696 genes with both copy
number and expression log-ratios available. Here we wish
to investigate if there are copy number changes that affect
expression levels within the same chromosome arm. We
report results controlling the FDR at 10%. Considering the
copy number data on a continuous scale, we fit the gene-
set model explaining measurements for each copy
number probe by the expression levels of all probes on the
same chromosome arm. This model found evidence of
association between copy number and expression levels,
with in total 343 probes significant out of 4696 (figure 2).
The gene-to-gene model can be applied directly as the
same microarray was used both for copy number and for
expression. This model selected 272 clones, 114 of which
also selected by the gene-set model (see figures 1 and 2A
in Additional Files 1 and 2). This shows that the gene-to-
gene model finds some of the same effects as the gene-set
model, but each one finds unique effects: 158 by the gene-
to-gene model, 229 by the gene-set model.
Some of the effects found by both models identify copy-
number aberrant regions such as those on 8p, 8q, 17q and
20q (figure 2). In particular, 17q includes genomic
regions with high-amplitude copy number effects (ampli-
fications) highly associated with resident-genes' expres-
sion levels (figure 3A). One of these regions contains the
ERBB2 gene, another one contains the TRAF4 gene. These
genes were also found by Pollack [12], and are known to
be involved in breast cancer development. Other candi-
date oncogenes were identified in gained regions 8p11-12
(including LSM1, BAG4 and FGFR1) and on 20q (includ-
ing NCOA3). In other instances the models yield different
results. In general, the gene-set model finds regions of
association, i.e. it tends to find associations involving
neighbouring copy number probes. In contrast, the gene-
to-gene model focuses on effects on individual probes, so
it often finds single probes with association with no other
effects on neighbouring probes. On chromosome arms
3p, 3q, 14q and 18q (figure 2D), both models pick up at
least one copy number probe as having association with
expression within those arms, but the effects span
genomic regions under the gene-set model, whereas they
are restricted to individual probes under the gene-to-gene
model. Looking in more detail at 18q, many samples have
a mild copy loss of up to -0.4 on the median smooth scale,
with a handful of samples displaying slightly larger losses
(see figure 4A). A couple of samples display mild copy
gain in the same region. It turns out that expression is
affected, as indicated by the many statistically significant
associations found by the gene-set model. The gene-to-
gene model, however, only finds three of those associa-
tions statistically significant.
In general, the gene-set model particularly benefits from
(mild) associations spanning multiple genes. If expres-
sion levels of resident genes are affected, many copy
number probes mapping the aberrant region will show
significant associations, thereby highlighting the region.
On the other hand, copy number changes that affect only
one or a few genes are picked up by the gene-to-gene
model, but may become diluted when the entire chromo-
some arm is analysed by the gene-set model. For example,BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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associations on 9q and 11q are only detected with the
gene-to-gene model (Figure 2C).
Breast cancer II: Chin
Let us now consider a set of 89 samples of breast tumor
tissue, profiled both on a 2.5 K BAC array CGH and on an
A3ymetrix U133A array from Chin and co-authors [29]. In
this case there is no correspondence between copy
number and expression probes, and the genomic coverage
is rather different from the one yielded by Pollack's cDNA
arrays, with the copy number arrays having about half the
number of clones as in Pollack's data, and the expression
arrays having over four times as many probes as Pollack's.
Only probes with genomic annotation were used, total-
ling 2083 BACs and 21339 expression probe sets. Here we
used again in the gene-set model all genes on a chromo-
some arm as a gene set. For all models applied to this data-
set, associations found are those considered statistically
Receiver-operator characteristic curves for the simulation study Figure 1
Receiver-operator characteristic curves for the simulation study. Conditions shown are: sample size 25, 50 and 100 
(rows from top to bottom); length of the studied region 500 and 1000 probes (columns from left to right); proportion of sam-
ples with each effect 10, 25 and 50 percent (solid, dashed and dotted lines); and copy number effect sizes 2, 0.5 and -0.85 (line 
colours red, green and purple). For details about the study setup, see appendix.
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 500 probes, s.size 25
2
0.5
í
0.1
0.25
0.5
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 500 probes, s.size 50
2
0.5
í
0.1
0.25
0.5
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 500 probes, s.size 100
2
0.5
í
0.1
0.25
0.5
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 1000 probes, s.size 25
2
0.5
í
0.1
0.25
0.5
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 1000 probes, s.size 50
2
0.5
í
0.1
0.25
0.5
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 1000 probes, s.size 100
2
0.5
í
0.1
0.25
0.5BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
Page 5 of 15
(page number not for citation purposes)
significant with FDR control at 1%. This more strict
threshold is used to make results more comparable with
those from the previous example, where the number of
samples (41) was less than half of the number of samples
here.
First we fit overlap and window gene-to-gene models. The
overlap gene-to-gene model, measuring association
between copy number on BAC clones and expression
probe sets included in it, yields 991 comparisons repre-
senting less than half of the copy number probes observed
(2083). In contrast, the 2 Mb-window gene-to-gene
model involves 2030 comparisons. So by considering
only expression probes located within BACs more than
half of the BACs is neglected. In addition, the associations
considered by the overlap model are also considered by
the window model by definition, unless the window used
in the latter is smaller than the BACs, which is not the case
here. So we expect to identify the same associations with
both models, which indeed happens: of the 239 statisti-
cally significant associations identified by the overlap
model, only 13 were not identified by the window model
too. This is merely because, by involving a much smaller
number of tests, the overlap model results involve a less
severe multiple-testing correction. From this viewpoint
the overlap model yields the same patterns as the window
model, but the latter makes better use of the observed
data. For this reason, we will focus hereafter on compari-
sons between the window gene-to-gene and the gene-set
models. The genomewide associations found between
copy number and gene expression with these two models
can be seen in Additional File 3.
There are many associations found both by the gene-set
and by the gene-to-gene model, but also associations
found by only one (see figure 1B in Additional File 1). The
many effects found by both models refer to those involv-
ing large enough copy number changes and/or expression
changes. For example, we found a pattern of association
on 17q with both models, very similar to what had also
been found in the previous example (figure 3B). This may
sound obvious, but it is less so considering the widely dif-
Overview of associations found with Pollack's breast cancer data and the gene-set model Figure 2
Overview of associations found with Pollack's breast cancer data and the gene-set model. Chromosomes are rep-
resented by horizontal bars, and the arms are the gene sets used, with gene set edges marked by triangles and stars. Each ver-
tical bar represents one copy number probe. The colour of the bar indicates the test result: blue, significant(FDR ≤ 0.10); grey, 
not significant (FDR > 0.10). Results on the left-hand side (A) refer to all tests done on the Pollack data set using the gene-set 
model. Insets on the right-hand side display gene-set (top) and gene-to-gene (bottom) p-values for a selection of chromosome 
arms (B: 17q, C: 9q and 11q; D: 3p, 3q, 14q and 18q).
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Association patterns between copy number and gene expression found on 17q for two independent breast cancer studies Figure 3
Association patterns between copy number and gene expression found on 17q for two independent breast 
cancer studies. Heatmap of association structure (green, positive; red, negative; black, no association) for the datasets of Pol-
lack (A) and Chin (B), with rows representing copy number probes from centromere (bottom) to telomere (top), and columns 
representing gene expression probes from centromere (left) to telomere (right). The vertical bars on the left-hand side repre-
sent the p-values for the copy number probes, as calculated by the gene-set model (bar I) and by the window gene-to-gene 
model (bar II), with blue indicating the significant ones (for Pollack FDR ≤ 0.10, for Chin FDR ≤ 0.01). The top horizontal bar 
indicates expression probes with strong positive (green) or negative (red) association with the significant results from the 
gene-set model (mean z-score across significant tests ≥ 3). In the left panel, the log-ratio copy number values for all samples are 
represented by their smoothed medians, on the same probe spacing (equal space between each pair of consecutive probes) as 
used in the heatmap for comparability.
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ferent microarray platforms used in the two studies, with
markedly different genomic coverages, and the fact that
independent samples are involved. Reflecting this, the
number of probe sets mapping 17q differs markedly
between the two studies: Pollack has 215 clones measur-
ing both copy number and expression levels, whilst Chin
has only 59 measuring copy number and as many as 913
measuring expression.
For some regions, the gene-set and gene-to-gene models
yield different results. As in Pollack's data, for 18q the
gene-set model finds clear association between copy
number and expression for all but three clones in the
region, in contrast with a weaker association detected by
the gene-to-gene model (figure 4B). Indeed, copy number
changes in this region are mild, with most changes being
a loss of no more than 0.4 on the smoothed median scale.
But many samples do display this loss, and its impact on
expression drives the association. This mild effect is
harder to be picked up by the gene-to-gene model.
An intermediate model between the gene-set on the chro-
mosome arm and the gene-to-gene (on a 2 Mb window)
models would be one that considers a smaller gene set,
helping focus the search for associations in the region
around the copy number probe. Such a gene set may be
defined in various ways. Here we consider as gene set all
gene expression measurements within a 2 Mb region cen-
tered around the copy number probe under study. As
expected, this model finds many associations also identi-
fied by the other models, but also finds some more (see
Additional File 4). Of the 2030 associations tested by all
three models, 1344 (66%) were found to be statistically
significant by at least one model and, of those, 519 (39%)
were found by all three models. The largest overlap was
found between the gene-to-gene and the gene-set on the 2
Mb window, with 775 associations found in common,
which is reasonable. However, there were also associa-
tions found by each model individually, with the different
models specializing in different effect types. This is further
illustrated by re-examining significant associations found
on chromosome 17 (Additional File 5).
Population data: HapMap
Gene dosage, as copy number variation is often referred to
in a biological context, plays a role in regulating gene
expression in normal individuals, as was shown by the
analysis of copy number and expression data from the
HapMap2 samples [22]. Such effects tend to be milder
than those found in cancer data, since copy number
changes will be typically smaller in size here. Here we
illustrate that the gene-set model also has the power to
find associations in this context, where mild effects are
measured by higher-density arrays. We have re-analysed
the data using the gene-set model over each chromosome
arm. For comparability with Stranger's results, our model
explains the expression levels of each individual probe by
the copy number values of all BAC clones in the same
chromosome arm, in contrast with the first two examples.
This means that around 18 K gene expression probes were
tested for association with copy number. Our results
yielded similar numbers of gene expression probes
selected at the same p-value threshold, but the overlap
with the probes selected by Stranger was relatively small
(see supplementary table 1 in Additional File 6). A thor-
oughcomparison between our results and Stranger's is not
our objectivehere. Rather we wish to show the added-
value of the gene-set model compared to gene-to-gene
models, such as the one used by Stranger. The gene-set
model had more power to detect subtle associations that
span at least a few probes. Indeed, we have identified a
region on 6p where gene expression displays association
with some of the copy number probes, within each of the
populations. The region goes from 32.593 to 32.817 Mb
and includes four expression probes. Using a gene-to-gene
model, Stranger only picked up two of these four gene
expression probes as being associated with copy number,
and only for one of the four populations. The gain in
power was thus significant by including many BACs in the
model, in spite of the fact that the relevant association
only involves a small number of BACs (four), compared
to the total included in the model (607) on 6p. With the
largest Pearson correlation between BAC clones and
expression probes in this region being less than 80%, the
effect seems not to be strong enough to be picked up using
individual BACs as Stranger did. Note that the four expres-
sion probes selected map major histocompatibility com-
plex class II genes, known to harbour polymorphisms that
are commonly genotyped prior to organ transplants. Thus
these known polymorphic areas have copy number-regu-
lated gene expression, but that was only detected by the
gene-set model.
Discussion
We propose to jointly analyse DNA copy number and
mRNA expression array data by modelling one (copy
number, say) as a function of the values of the other
(expression) for all genes in the same chromosomal arm
or an independently defined region. This yields a gain in
power to detect associations, as genome-based regulatory
mechanisms tend to affect neighbouring genes. Consider-
ing the coordinate behaviour of groups of genes instead of
individual genes was shown to be a useful strategy to
improve robustness in gene expression analysis [30-32],
but has not been previously used in the context of inte-
grating expression data to another data type. Because the
global test, the basis of our approach, has optimal power
to detect subtle but consistent association between phe-
notype and expression signature [33], it enables us to
detect associations between expression levels and low-BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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Association patterns between copy number and gene expression found on 18q for two independent breast cancer studies Figure 4
Association patterns between copy number and gene expression found on 18q for two independent breast 
cancer studies. Heatmap of associations for 18q. See figure 3 for a detailed description.
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level gains, in contrast with previous papers which had
only been able to detect associations involving high-level
gains [11,13,15,23,28].
Our approach is unique in several ways. Firstly, by consid-
ering the association between each probe in the depend-
ent data and a gene set in the independent data, rather
than a single gene, it stands a better chance of detecting
subtle but consistent effects across many genes. Indeed,
we have shown in a simulation study that subtle effects
can indeed be found if at least 50 samples are studied. As
key parameters of the study were estimated from tumor
datasets, such as copy number and expression variability
as well as their association, results can be extended
directly to other studies. As further confirmation, associa-
tions between large- and small-amplitude copy number
changes and gene expression levels were also found in the
breast cancer datasets studied. The use of gene sets keeps
focus on consistent changes that are unlikely to be data-
dependent, as we showed by obtaining similar patterns of
association for two independent datasets, in spite of
widely different microarray platforms having been used.
Secondly, the use of a regression framework means that
our model enables control of confounder effects. For the
samples studied by Chin estrogen-receptor status was
known. We applied the gene-set model using this variable
as a confounder. Associations found were similar to those
without considering the confounder for most chromo-
somes, except for five of them: for 1p, 5q, 6p and 12q, no
features were selected with ER-status adjustment whilst
the unadjusted model selected between 20% and 60% of
the probes, and for 19q, no features were found with the
unadjusted model, but about 40% of the BACs were
selected with ER-status adjustment. More importantly, in
each of these chromosome arms a handful of BACs was
assigned an FDR-corrected p-value in one analysis below
0.01, whilst in the other the p-value was larger than 0.20.
These results suggest that copy number-based mecha-
nisms of gene expression regulation differ according to
estrogen-receptor status in breast cancer.
Thirdly, our model can be used with continuous copy
number, as log-ratios like in our examples or on the orig-
inal copy number scale, as well as segmented or discre-
tized copy number data. Here we point out that there is no
consensus as to whether or not association testing would
benefit from segmentation of DNA copy number data
[22,24,34]. However, we recommend using continuous
data at least in cancer studies, because a non-integer
number of copies may represent the average number of
copies found on the sample of cells collected for that par-
ticular tumor, in which case a sharp cut-off is likely to
introduce a bias.
Finally, our approach avoids introducing bias via match-
ing between copy number and expression probes on the
genome, as it rightly focuses on finding relevant associa-
tions regardless of their genomic location. We compared
the performance of the gene-set model to that of the gene-
to-gene model. While the former has more power to iden-
tify regions with coordinated association, the latter yields
individual associations unrelated to possible effects in its
neighbourhood, as expected. Associations involving a
large proportion of samples displaying a large-amplitude
copy number change are typically picked up by both mod-
els, as is the case on 17q, known to harbour regions of
large amplifications that play a causal role in breast can-
cer. Mild associations, because either the copy number
change has small amplitude, or the effect on gene expres-
sion is limited, or even the proportion of samples
involved is small, are less likely to be identified by the
gene-to-gene model than by the gene-set model. A clear
example is that of 18q, where in both examples the gene-
set model identifies the effect spanning a large region, but
the gene-to-gene model just selects a handful of probes.
Note, however, that the overlap between results of the two
models for the Chin dataset is positively associated with
window size and, as the 2 Mb window size used included
most of the associations available, considerable overlap
was the result.
From the biological viewpoint, associations found for
many copy number probes within the same region are
reassuring, as they are less likely to be driven by pure
noise. Because it tends to find regions of association, the
gene-set model is more robust to noise than the gene-to-
gene model.
These two models represent two extremes. An intermedi-
ate model may be used to diminish the dilution, whilst
still being robust to noise. Such a model could be a gene-
set model over a window centered around the copy
number probe, as used in the Breast Cancer II example.
This sort of model is particularly useful when interest lies
in mild associations, either spanning small regions,
involving low-amplitude copy number changes or having
a limited impact on expression levels. It might be particu-
larly useful when high-density arrays are involved. Never-
theless, the gene-set model remains the least arbitrary and,
while dilution might be a concern, individual effects may
still be identified by visual inspection of heatmaps repre-
senting association patterns found. In such cases, focus
shifts from finding statistically significant associations to
finding consistent association patterns between copy
number and expression. The nature of the problem turns
then from that of hypothesis testing to an exploratory one.
We considered two ways in which the gene-to-gene model
(1) can be used in a study where different microarray plat-BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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forms were used to measure copy number and expression.
The first one involved considering only copy number and
expression probes that overlap, so that only measure-
ments for the same locus are considered. The second way
was to calculate associations between each copy number
probe and expression probes located within a certain dis-
tance from it. Another possible way is to interpolate the
copy number measurements, say using quantile smooth-
ing as suggested by Eilers and Menezes [35], and thus
obtain copy number estimates corresponding to all loci
for which expression was measured. This would avoid the
problem from the first approach that non-overlapping
probes are neglected, and the arbitrariness of defining a
distance on the second approach, so making use of all
observed measures. However, it relies on good approxi-
mations via interpolation. If the density of the copy
number probes is high with reasonably small intervals
between probes, interpolated values tend to estimate well
the true copy number. On the other hand, with large
between-probe distances such as 1 Mb, this is less likely to
be the case. In all cases some arbitrariness is involved,
which the gene-set model avoids.
The gene-set model can be formulated in alternative ways
to answer different questions. Perhaps the most intuitive
formulation is to use expression as outcome and copy
number as explanatory variable, best suited to find genes
which expression is regulated by copy number changes in
the region around it. However, if the objective is to find
DNA-based markers that regulate gene expression on the
same region, then the best formulation uses copy number
as outcome and expression as explanatory variable, as we
did in the analysis shown here. By considering the expres-
sion values of many genes simultaneously, this formula-
tion is also able to capture coordinated variability in
expression levels across genes, such as co-regulation,
which would not be possible otherwise due to noise. This
is relatively less important in copy number data, which
typically displays relatively less noise compared to the sig-
nal.
It is straightforward to extend the model to analyse other
types of high-dimensional data. For example, another
type of expression regulation mechanism is DNA methyl-
ation, which can be measured via CpG-island arrays. In a
similar way to simultaneous analysis of copy number and
expression array data, there could be interest in analysing
DNA-methylation and expression. The use of gene sets are
still likely to improve power to detect associations, as
DNA-methylation may affect the expression levels of mul-
tiple genes, like copy number.
A second interesting extension is to consider more than
two types of array data in model (2). For example, gene
expression can be regulated by different mechanisms in
addition to copy number, including transcription factor
levels, sequence changes, DNA methylation, loss of heter-
ozygosity, and chromatin structure. Our method can be
generalized to analyze the association between gene
expression and other types of genomic information simul-
taneously. This extension is beyond the scope of this
paper and will appear elsewhere. We hope that such a
model taking into account multiple data sources simulta-
neously will shed light on the influence of different
genetic and epigenetic mechanisms on gene regulation.
Finally, while the gene-set model serves as a starting point
to identify copy number changes that are associated with
expression patterns, additional experiments are needed to
validate the possible role of these changes in the causation
or maintenance of the phenotype under study.
Conclusion
We have proposed, and given proof of principle for, a new
approach to identify association between high-through-
put genomic copy number and gene expression profiling
data, which can be used to identify putative candidate
genes involved in tumorigenesis. By considering the
expression levels of many genes simultaneously in the
model, our approach identifies regions of association
even if low-amplitude copy number changes are involved.
The regression is able to control for confounder effects.
Finally, it requires neither matching between copy
number and expression probes on the genome, nor cate-
gorization of copy number, both of which are possible
sources of bias.
Methods
We assume that each sample is profiled both on a copy
number and on an expression array, that the copy number
and the expression array data were separately pre-proc-
essed, adequately normalized and that probe annotation
including identifier, chromosome number and location
in base pairs is available.
We shall focus on answering the following question:
which copy number changes affect gene expression within
the same chromosomal region? This question typically
arises when searching for DNA-based markers that regu-
late expression via copy number change.
The gene-to-gene model
Since our main interest is to find DNA-based markers that
are associated with expression changes, it makes sense to
consider copy number as the dependent variable, so
expression is handled as the independent variable. The
simplest model to consider is
EY X n N i I ni i ni () , ,, , ,, , =+ = = ab 11 KK (1)BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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where Yni represents the copy number measured for sam-
ple n and array-CGH copy number probe i (i = 1,...,I) and
Xni represents the expression level for sample n and expres-
sion probe i. This model is written assuming that there is
a one-to-one correspondence between copy number and
expression probes, for simplicity, which holds for exam-
ple if the same array is used to measure both copy number
and expression levels. Such a model is especially useful if,
in addition to using the same array, the study goal is to
find associations between copy number change and
expression variation at the same locus. We shall refer to
(1) as the gene-to-gene model.
In many cases interest lies in studying effects of copy
number change on expression of resident genes, i.e., genes
within the same region where copy number was meas-
ured. But it can be the case that not the same array was
used to measure copy number and expression. Then
model (1) can still be used if the data and/or the model
are adapted. The first thing that can be done is to consider
only expression probes that fall within copy number
probes, so as to ensure that measurements relate to the
same locus. We refer to this as the overlap approach. This
is rather strict, and may result in many expression probes
not being considered, even if they are close to the copy
number probe. To relax this, we can consider expression
probes that are within a certain distance from the middle
of the copy number probe in each direction, and then fit
model (1) to each one separately. We refer to this as the
window approach, where the window size is the length of
the entire interval considered. This may yield more than
one test for some copy number probes, whilst for others
with no expression probes near it no tests are done. So
some arbitrariness is involved in defining the distance,
which directly affects which tests are considered. Here we
shall use a window of size 2 Mb (similar to Stranger et al.
[22]), centered around the start of the copy number
probe.
The gene-set model
In practice, it is not commonly the case that the same array
platform is used for copy number and expression. Moreo-
ver, the arbitrariness of the window definition is undesir-
able, and considering only overlapping probes leads
potentially to loss of valuable information. An ideal way
to avoid these problems is to include in the model all
expression probes within the same large region. This leads
us to the model, for each copy number probe i,
By considering the expression levels of many genes simul-
taneously, this model suits well most situations where
copy number changes produce an effect spanning many
expression probes, in a possibly subtle but consistent way.
Because (2) makes use of a set of genes as independent
variables, we shall refer to it as the gene-set model.
Note that the gene-set model (2) is not estimable if J > n,
in a classic linear regression context. Since our main objec-
tive is to test whether copy number change is associated in
general with expression levels {Xnj, j = 1,...,J}, it is natural
to study the distribution of β ≡ (β1,...,βJ)t, a vector of inde-
pendent random variables. We assume that each βj has a
certain distribution and, under the null hypothesis of no
association between X and Y, has mean 0 and variance τ2
≡ 0. The assumption β ~ (0, τ2IJ) means that model (2) is
a random-effects model, and a natural distribution to
assign to the vector β is the multivariate normal with a
covariance matrix τ2IJ, where IJ represents the identity
matrix with J rows. The random-effects model framework
arises thus naturally from the question under study and
the biological context. Moreover, it guarantees that model
(2) is identifiable, which would not be the case in the clas-
sic linear regression model framework if J >> N, which is
often the case. Thus, model (2) can be fitted using meth-
ods for random-effects models.
Under the alternative hypothesis of association, the mean
of each βj may still be zero, but their variance should be
strictly positive (τ2 > 0), suggesting that a non-empty sub-
set of the {Xnj, j = 1,..., J} is associated with copy number
measurements for probe i. Therefore, we shall focus on
testing H0 : τ2 = 0 against Ha : τ2 > 0. A test to compare such
null and alternative hypotheses was proposed by [30] for
testing association between expression levels of a set of
genes, e.g. those belonging to a biological pathway, with
a clinical outcome. This approach has been shown to have
more power to detect subtle associations than by perform-
ing separate tests and correcting the resulting p-values for
multiple testing [33]. We shall make use of this global test
as the basis for our approach in this new context, as well
as consider extensions of interest.
By modelling the copy number at each locus by expres-
sions within a large gene set, the gene-set model (2) takes
advantage of the typically larger signal-to-noise ratio in
copy number compared with gene expression microarray
data. By considering the expression levels of many genes
jointly, coordinated expression changes, such as co-regu-
lation, are more likely to be detected than if gene expres-
sion levels were considered separately.
Considering covariates
Because models (2,1) are constructed within a regression
framework, other explanatory variables which can act as
confounders can be included. This is very important in
more complex designs, such as when more than one sam-
EY X n N ni j nj
j
J
() , ,, . =+ =
= å ab
1
1 K (2)BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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ple is collected per patient, when patients are related, or
when clinical variables are to be taken into account, for
example tumor location and age.
Note that, as in multivariate regression analysis, the inclu-
sion of a confounder can weaken or even eliminate an
effect, if the association is limited to one confounder-
defined subgroup. On the other hand, it may explain part
of the copy number variation bringing out new associa-
tions.
Multiple testing correction
Both models (1) and (2) yield one p-value per copy-
number probe tested. Copy number levels of neighbour-
ing probes are likely to be associated, but genomic breaks
such as centromeres and telomeres may break this associ-
ation. Therefore, it seems reasonable to treat chromo-
somal arms independently in the analysis, including in
what concerns multiple testing correction. The correction
must allow for dependency between the tests, and cur-
rently the most adequate method available has been sug-
gested by [36].
Note that the overlap and window approaches used with
the gene-to-gene model (1) involve different numbers of
tests, implying different multiple testing corrections,
unless of course the same microarray is used to measure
both copy number and expression. Indeed, the overlap
approach typically will involve a smaller number of tests
than there are copy number probes, in contrast with the
window approach which may generates a larger number
of tests than there are copy number probes.
Definition of genomic region
The length of the genomic region under study may affect
the results of the model fit via the amount of multiple-
testing needed and, to a lesser extent, via the number of
explanatory variables, i.e. gene expressions, in the model.
To avoid introducing bias in this way, we suggest that the
genomic regions to be studied be determined a priori. In
our experience chromosome arms are sensible such
regions, as are minimal common regions of recurrent
copy number aberrations.
Visualization and prioritization of genes
For each copy number probe, the test statistic can be
decomposed into the individual contributions of the
genes' expression levels [30]. After standardization per
probe, we display the separate contributions of the gene
expressions to copy number variability by means of a
heatmap, where rows and columns represent copy
number and expression probes respectively, both kept in
their genomic order. If a copy number change spanning
roughly the same genomic region across a subset of sam-
ples is positively associated with gene expression on the
same region, it will be represented by a green rectangle on
the diagonal. For each copy number probe, discretised p-
values computed with the test can be displayed as a verti-
cal bar next to the heatmap, so that significantly associ-
ated genomic regions are highlighted.
It is often of interest to identify the gene expression probes
with the largest contributions to the test results, in some
sense. We choose to compute the mean standardized con-
tribution over all significant tests, per expression probe,
then rank them to generate candidate genes for future
investigation. This yields candidate genes whose expres-
sion levels are highly associated with copy number. By
considering only the significant tests, we want to avoid
diluting a possible association spanning a relatively small
area, compared to the entire area under study.
Software used
We have used R version 2.5.1 [37] for all our analyses. In
addition, we used the following R packages: globaltest,
marray, multtest and quantsmooth. An R package called
SIM implementing this approach has been made available
via BioConductor.
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Appendix
Simulation study setup
Assumptions
In order to evaluate how the regional integration model
works, we run a simulation study. For this, we assume for
simplicity that both copy number and expression meas-
urements are obtained using the same arrays, so that there
is a one-to-one correspondence between them. We also
assume that the copy number is measured in terms of log-
ratios, that the expression is measured in terms of intensi-
ties, and that the datasets were normalized separately as
adequate. All these assumptions are made for the sake of
simplicity, being unimportant for the qualitative results of
this study.
For each probe i = 1,...,I, the data consists of copy number
measurements  Yi1,...,YiN  and expression measurements
Xi1,...,XiN for samples 1,...,N. We assume that samples are
independent and that data distribution is independent of
sample, so we ignore the sample index from now on for
simplicity. The true log-ratio copy number of gene i is rep-
resented by ξi. We represent by Zi the binary indicator var-
iable that copy number of gene i regulates its expression,BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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so that the vector Z = (Z1,...,ZI)t represents expression-reg-
ulating copy number regions. We assume that there are
three such regions: region I, spanning 20 probes which all
have true copy number 5, so a gain of 3 copies; region II,
spanning around 26% of the probes which all have true
copy number 3, so a gain of one copy; and region III,
spanning also 26% of the probes which all have true copy
number 1, so a loss of one copy.
Copy number measurements Y1,...,YI are assumed to be
independent, each Yi with distribution N(ξi, ). Note
that if gene i  is located in any of the three regions of
expression-regulating copy number, Zi = 1 and ξi ≠ 0 and,
for all genes outside these regions, Zi = ξi = 0.
Expression measurements X1,...,XI are assumed to be con-
ditionally independent, given Y1,...,YI, with
(Xi|Yi)~N(μi{1+αiξi}, ), where μi  represents gene i's
baseline expression level, and αi is a variable representing
the extent to which copy number of gene i regulates its
expression.
Parameter values
The mean log-ratios of copy numbers ξi|Zi = 1 were esti-
mated from [38], which made use of commercially avail-
able DNA samples with known copy number. These data
yielded ξi = 2, ξi = 0.5 and ξi = -0.85 for genes in regions I,
II and III respectively. Note that there is signal compres-
sion of the expected amplitude. Log-ratios of copy num-
bers {Yi, i = 1,...,I} were drawn independently from a N(ξi,
) where its dispersion 1/  follows a Γ(2, 2), so the
mean dispersion is 4. Given Yi, μi is drawn from a N(9.5,
2.32), independently for each i. The dispersion of Xi|Yi, 1/
, is in its turn drawn from a Γ(2, 0.5), implying that the
mean dispersion is 1.
Copy-number impact on expression per probe i, αi, was
estimated using three subregions of the breast cancer data
from [12], as in this case the same array was used to pro-
duce both copy number and expression. These three
regions were chosen so as to contain copy number
changes, some of them having been found to be associ-
ated with expressions, and were located in chromosomes
1q, 8p and 17q. First of all, the relationship between copy
number and expression for the 303 selected probes can be
described reasonably well by a linear function (data not
shown). Moreover, the normal distribution seems to yield
a reasonable approximation to the empirical distribution
of αi, with mean and variance estimated as -4.6 and 8.3,
respectively (data not shown). So, in our simulation we
draw αi from this distribution. Other parameters that need
to be fixed and values used are given in supplementary
table 2 (see Additional File 6).
Note that the direction of the effect (positive or negative)
is unimportant for its detectability by the model, only the
log-ratio is important.
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Additional file 1
Overview of associations found with Pollack's breast cancer data and 
the gene-to-gene model. Results obtained with the gene-to-gene model, 
where association is measured between each pair of copy number and gene 
expression measures obtained with the same cDNA clone. Chromosomes 
are represented by horizontal bars, with telomeres and centromeres 
marked by triangles and stars respectively. Each vertical bar represents one 
copy number probe. The colour of the bar indicates the test result: blue, 
significant(FDR ≤ 0.10); grey, not significant (FDR > 0.10).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-203-S1.pdf]
Additional file 2
Venn diagram of associations found by two models in two independent 
breast cancer studies. Overlap of associations between copy number and 
expression found significant by the gene-set (right, in blue) and gene-to-
gene (left, in red) models. For the gene-set model, the chromosome arm 
was used as gene set. A – Pollack's data (FDR ≤ 0.10); B – Chin's data 
(FDR ≤ 0.01), for which the gene-to-gene model was applied on a 2 Mb 
window.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-203-S2.pdf]
Additional file 3
Overview of associations found with Chin's breast cancer data. Chro-
mosomes are represented by horizontal bars, with centromerers and telom-
eres marked by triangles and stars. Each vertical bar represents one copy 
number probe. The colour of the bar indicates the test result: blue, signif-
icant (FDR ≤ 0.01); grey, not significant (FDR > 0.01). A: gene-set 
model; B: gene-to-gene model.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-203-S3.pdf]
Additional file 4
Venn diagram of associations found by three models with Chin's 
breast cancer data. Overlap of associations between copy number and 
expression found significant by the gene-set model using chromosome arm 
(right), the gene-set model using only gene expression probes on a 2 Mb 
window around the copy number probe (bottom) and the gene-to-gene 
model applied to the same 2 Mb window. Significance threshold was taken 
as FDR ≤ 0.01.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-203-S4.pdf]BMC Bioinformatics 2009, 10:203 http://www.biomedcentral.com/1471-2105/10/203
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